Search
What are you looking for?
Start main content

Press Releases

Press Releases

https://www.med.cuhk.edu.hk/press-releases/cuhk-receives-an-international-cancer-care-team-award-nominated-by-patients
https://www.med.cuhk.edu.hk/press-releases/cuhk-receives-an-international-cancer-care-team-award-nominated-by-patients

CUHK Receives an International Cancer Care Team Award Nominated by Patients

The Department of Clinical Oncology of the Faculty of Medicine at The Chinese University of Hong Kong (CUHK) has recently been bestowed the International Association for the Study of Lung Cancer (IASLC) Foundation Cancer Care Team Award, recognising its multidisciplinary team for providing outstanding  care for lung cancer patients. Nominations for the Award were made by patients from all over the world. The CUHK’s lung cancer team, led by Dr. Herbert Ho Fung LOONG, Assistant Professor (Clinical) of the Department of Clinical Oncology, Faculty of Medicine at CUHK, received the award for the “Asia & Rest of World” region. His team members include oncologists, nurses, research assistants and pharmacists.

 

Patients Nominate the Multidisciplinary Team for Excellent Cancer Care

Lung cancer is the most common cancer in the world. More than 1.6 million people die of this disease every year and more than half of the new cases occur in Asia. To recognise the multidisciplinary teams that provide the highest quality care for lung cancer patients, the IASLC Foundation established the “Cancer Care Team Award”. Awardees are nominated by patients from all over the world for outstanding medical teams. Winning teams are selected from North America, Latin America, Europe, and Asia & Rest of World.  

 

The multidisciplinary team of the Department of Clinical Oncology of the Faculty of Medicine at CUHK, including 13 experts from different medical fields, received the 2018 IASLC Foundation Cancer Care Team Award for Asia & Rest of World.

 

Professor Tony Shu Kam MOK,Li Shu Fan Medical Foundation Professor of Clinical Oncology and Chairman of the Department of Clinical Oncology of the Faculty of Medicine at CUHK, stated, “The recognition from IASLC has encouraged both me and the team. Lung cancer is the most common cause of cancer death in Hong Kong. With advances in medical research, there are more new lung cancer treatments related to different genetic variants coming up. Providing the best personalised care for patients is the goal of our team and the entire Department. We hope to provide patients with a good quality of life when they are living with the disease.”

 

Dr. Herbert Ho Fung LOONG,who led the award-winning team, is deeply honoured by the Award. Dr. LOONG said, “The significance of the Award is that it is directly nominated by patients. It means our patient-oriented treatment approach meets the needs of patients and is agreed by them. The clinical oncology team of the CUHK Faculty of Medicine will continue to strive to give lung cancer patients the best care through the multidisciplinary collaborations among different disciplines, including oncologists, nurses, research assistants and pharmacists.”

 

Twenty Clinical Trials for Lung Cancer to Provide Patients with More Treatment Options  

The Department of Clinical Oncology of the Faculty of Medicine at CUHK is an integrated academic and clinical unit providing state-of-the-art cancer care for over 5,300 new patient consultations annually, including over 800 new lung cancer cases. The Department provides quality cancer care ranging from active treatment to palliative care and hospice services in both inpatient and outpatient settings through a multidisciplinary approach by a dedicated team of oncologists, palliative medicine specialists, nurses, radiation therapists, medical physicists, clinical pharmacists and other allied health professionals.  

 

To improve treatment outcomes, the Department provides patients with opportunities to participate in clinical trials for more treatment options. Currently, there are over 20 active lung cancer clinical trials co-ordinated through the Comprehensive Cancer Trials Unit in collaboration with the CUHK Phase 1 Clinical Trial Centre.

 

About the International Association for the Study of Lung Cancer  

The International Association for the Study of Lung Cancer (IASLC) is a global organisation dedicated to the study of lung cancer and other thoracic malignancies. Founded in 1974, the Association's membership includes more than 7,500 lung cancer specialists who form a global network through over 100 countries. It has been built to conquer cancers that occur in the lung and the thoracic cavity worldwide. For more details, please visit the website of IASLC: www.iaslc.org.

 

The multidisciplinary team of the Department of Clinical Oncology of the Faculty of Medicine at CUHK receives the 2018 IASLC Foundation Cancer Care Team Award. The team is led by Dr. Herbert LOONG (6th from left), Assistant Professor (Clinical) of the Department, and the team members include oncologists, nurses, research assistants and pharmacists. (5th from right) Professor Tony MOK, Li Shu Fan Medical Foundation Professor of Clinical Oncology and Chairman of the Department of Clinical Oncology of the Faculty of Medicine at CUHK.

The multidisciplinary team of the Department of Clinical Oncology of the Faculty of Medicine at CUHK receives the 2018 IASLC Foundation Cancer Care Team Award. The team is led by Dr. Herbert LOONG (6th from left), Assistant Professor (Clinical) of the Department, and the team members include oncologists, nurses, research assistants and pharmacists. (5th from right) Professor Tony MOK, Li Shu Fan Medical Foundation Professor of Clinical Oncology and Chairman of the Department of Clinical Oncology of the Faculty of Medicine at CUHK.

Dr. Herbert LOONG (1st from left) and some members of the award-winning team received the IASLC Foundation Cancer Care Team Award at the IASLC 19th World Conference on Lung Cancer in Toronto in September 2018.

Dr. Herbert LOONG (1st from left) and some members of the award-winning team received the IASLC Foundation Cancer Care Team Award at the IASLC 19th World Conference on Lung Cancer in Toronto in September 2018.

More Press Releases

CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

CUHK in collaboration with West China School of Medicine co-Led World’s First-in-human Clinical Trial using CRISPR technology for lung cancer Confirmed gene-edited T-Cell Therapy is Safe and Feasible in Treatment of Advanced NSCLC

Research
CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

CUHK to Commence the Next-Generation Clinical Trials of CAR-T Cell Therapy for Haematological Malignancy

Research
Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Professor Tony MOK Honoured with the ESMO Lifetime Achievement Award Recognising His Global Leadership in Defining Lung Cancer Treatment Standard

Awards and honors
CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

CUHK-led Global Study Sees Improvement in Overall Survival in Patients with Advanced Lung Cancer

Research
A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

A CUHK-led International Study Demonstrates Immune-checkpoint Inhibitor Is Effective in Patients with Advanced Nasopharyngeal Cancer

Research
CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

CUHK Study Proves Ablative Chemoembolization Doubles the Progression-Free Survival for Liver Cancer Patients

Research
CUHK Research Receives Recognitions by Top Medical Journals

CUHK Research Receives Recognitions by Top Medical Journals

Awards and honors
CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

CUHK-led Research Confirms Novel Targeted Therapy Doubles the Effectiveness of Current Standard Treatment for ALK-Positive Lung Cancer

Research
CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

CUHK Unravels the Whole Genome of Nasopharyngeal Cancer A Great Leap Forward in Personalized Medicine Development

Research
CUHK Professor Dennis LO Receives 2021 Breakthrough Prize, an Honour Renowned as the “Oscars of Science”

CUHK Professor Dennis LO Receives 2021 Breakthrough Prize, an Honour Renowned as the “Oscars of Science”

Awards and honors
Insights into B-cells and GPR18 Gene Expression by CU Medicine team  Improve Prediction of Survival in Multiple Cancer Types

Insights into B-cells and GPR18 Gene Expression by CU Medicine team Improve Prediction of Survival in Multiple Cancer Types

Research
CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

CU Medicine Team Discovers a Novel Prognostic Biomarker for a Doubled Survival in Head and Neck Cancer

Research
Two CUHK Scholars Named World’s “Top 20 Translational Researchers” Professor Dennis Lo Receiving the Honour for the Third Consecutive Year

Two CUHK Scholars Named World’s “Top 20 Translational Researchers” Professor Dennis Lo Receiving the Honour for the Third Consecutive Year

Awards and honors
Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Two CUHK Scholars from the Faculty of Medicine Receive Croucher Senior Medical Research Fellowships

Awards and honors
CUHK Medicine Professor Juliana Chan Receives International Honour for  Outstanding Research and Care in Diabetes

CUHK Medicine Professor Juliana Chan Receives International Honour for Outstanding Research and Care in Diabetes

Awards and honors
CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

CUHK Successfully Conducts Asia-Pacific’s First Hybrid Operating Room Non-invasive Bronchoscopic Microwave Ablation to Treat Lung Cancer

Surgical advancement
李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

李嘉誠基金會啟動《愛能助》兒童癌症項目 資助兒童罕見癌症 (Chinese version only)

Donation
Professor Francis CHAN as the First Chinese Honoured with the American College of Gastroenterology International Leadership Award 2018

Professor Francis CHAN as the First Chinese Honoured with the American College of Gastroenterology International Leadership Award 2018

Awards and honors
Professor Dennis LO Being Named as World’s “Top Translational Researchers” for Two Consecutive Years

Professor Dennis LO Being Named as World’s “Top Translational Researchers” for Two Consecutive Years

Awards and honors
CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

CUHK Launches Multi-Cancer Prevention Programme Providing Free Screening to 10,000 HK Residents to Study Links with Obesity

Health Campaign
CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

CUHK Study Sees Increasing Global Incidence of Colorectal Cancer Among Younger People

Research
CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

CUHK Pioneers Early Lung Cancer Treatment with Hybrid Operating Room Image Guided Electromagnetic Navigation Bronchoscopy

Surgical advancement
Two CUHK Research Projects Receive State Science and Technology Awards

Two CUHK Research Projects Receive State Science and Technology Awards

Awards and honors
Two CUHK Medical Professors Winning WuXi PharmaTech Life Science and Chemistry Awards

Two CUHK Medical Professors Winning WuXi PharmaTech Life Science and Chemistry Awards

Awards and honors
CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

CUHK-HKU Study on Multi-gene Mutation-Drug Matching for Recurrent Ovarian Cancer Patients Providing Free Pharmacogenomic Analysis for 100 Patients in Hong Kong

Research
CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

CUHK Completes a 20,000-person Plasma DNA Screening Study of Nasopharyngeal Cancer, and Finds a Dramatic Shift to Early Stage Cancers

Research
CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

CUHK Uncovers Novel Immune Escape Mechanism of Cancer Opening Up New Direction for Cancer Immunotherapy

Research
‘Science is an Integral Part of My Life’ CUHK’s Prof. Dennis Lo Reaps Inaugural Future Science Prize

‘Science is an Integral Part of My Life’ CUHK’s Prof. Dennis Lo Reaps Inaugural Future Science Prize

Awards and honors
CUHK Professor Receives World Honour For Stroke Services Pioneering an Innovative 3-in-1 Multi-Target Therapy to Repair Damaged Brain After Stroke and Enhance Functional Recovery

CUHK Professor Receives World Honour For Stroke Services Pioneering an Innovative 3-in-1 Multi-Target Therapy to Repair Damaged Brain After Stroke and Enhance Functional Recovery

Awards and honors
CUHK Professor Dennis Lo Named ‘Thomson Reuters Citation Laureate’, an Honour Considered as an Index to Predict Nobel Prize Winners

CUHK Professor Dennis Lo Named ‘Thomson Reuters Citation Laureate’, an Honour Considered as an Index to Predict Nobel Prize Winners

Awards and honors
CUHK Professor Dennis Lo Receives Future Science Prize – Life Science Prize, the China's Nobel Prize

CUHK Professor Dennis Lo Receives Future Science Prize – Life Science Prize, the China's Nobel Prize

Awards and honors
CUHK Professor Hui Yao LAN’s Research on Chronic Kidney Disease Wins First Prize in Chinese Medical Science and Technology Award

CUHK Professor Hui Yao LAN’s Research on Chronic Kidney Disease Wins First Prize in Chinese Medical Science and Technology Award

Awards and honors
CUHK Professor Dennis Lo as the First Chinese Honoured with AACC Wallace H. Coulter Lectureship Award

CUHK Professor Dennis Lo as the First Chinese Honoured with AACC Wallace H. Coulter Lectureship Award

Awards and honors
CUHK Professor Diana Lee Inducted as Fellow of American Academy of Nursing

CUHK Professor Diana Lee Inducted as Fellow of American Academy of Nursing

Awards and honors
CUHK Medical Student Wins Grand Prize in FameLab Contest Hong Kong to Compete in FameLab International in UK

CUHK Medical Student Wins Grand Prize in FameLab Contest Hong Kong to Compete in FameLab International in UK

Awards and honors
CUHK Professor Dennis Lo Received International Honour for Pioneering Research in Personalized Medicine

CUHK Professor Dennis Lo Received International Honour for Pioneering Research in Personalized Medicine

Awards and honors
CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

CUHK Succeeded in Animal Study and Clinical Case of Percutaneous Nanoknife New Breakthrough in Cancer Treatment

Research
CUHK Received Four Ministry of Education Higher Education Outstanding Scientific Research Output Awards The Highest Share among Hong Kong Institutions

CUHK Received Four Ministry of Education Higher Education Outstanding Scientific Research Output Awards The Highest Share among Hong Kong Institutions

Awards and honors
CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

CUHK Discovers Innovative ‘Flow Diverters’ (Pipeline) as Effective Treatment for Cerebral Aneurysms in Asia’s First Clinical Study in Collaboration with Seven Medical Centres

Research

Our Expert List

Many experts under the Faculty of Medicine are available for media interview.
Please click here for the expert list or contact us.